Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial Academic Article Article uri icon

Overview

MeSH Major

  • CA-125 Antigen
  • Fallopian Tube Neoplasms
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Preoperative Care
  • Tomography, X-Ray Computed

abstract

  • Pfizer Inc.

publication date

  • December 3, 2011

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(11)61613-9

PubMed ID

  • 22056247

Additional Document Info

start page

  • 1931

end page

  • 9

volume

  • 378

number

  • 9807